Tumors and Oncological Cases
Tumors and Oncological Cases is a research topic within Pathology and Forensic Medicine. Science Explorer counts 27k research works in it since 1950. 6.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the clinical and pathological characteristics, immunohistochemical assessment, and diagnostic challenges of granular cell tumors in various anatomical locations such as the breast, oral cavity, soft tissues, and gastrointestinal tract. It also discusses the distinction between benign and malignant granular cell tumors, along with their unique histological features.
- Granular Cell Tumor
- Immunohistochemical Assessment
- Clinical Correlation
- S100 Protein
- Ki-67 Proliferative Index
- Malignant Granular Cell Tumor
- Soft Tissues
- Breast
- Oral Cavity
- Pathological Characteristics
- Research works
- 27k fractional, since 1950
- In the world top 10%
- 1.7k per year above
- Top-10% rate
- 6.1% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +13% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Tumors and Oncological Cases research?
By volume, the United States and India publish the most (793 and 575 works in 2022–2025).
By volume, 2022–2025
- 1 United States 793 works
- 2 India 575 works
- 3 China 357 works
- 4 Japan 251 works
- 5 Brazil 177 works
- 6 Germany 127 works
- 7 Italy 116 works
- 8 United Kingdom 110 works
- 9 Spain 103 works
- 10 Türkiye 94 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Tumors and Oncological Cases research?
By volume in 2022–2025, All India Institute of Medical Sciences publishes the most Tumors and Oncological Cases research, followed by Mohammed V University and Post Graduate Institute of Medical Education and Research.
By volume, 2022–2025
- 1 All India Institute of Medical SciencesIndia 25 works
- 2 Mohammed V UniversityMorocco 19 works
- 3 Post Graduate Institute of Medical Education and ResearchIndia 14 works
- 4 Institute of Medical SciencesIndia 12 works
- 5 All India Institute of Medical Sciences BhubaneswarIndia 11 works
- 6 Mayo Clinic in ArizonaUnited States 10 works
- 7 Sichuan UniversityChina 10 works
- 8 Universidade de São PauloBrazil 9 works
- 9 Cleveland ClinicUnited States 9 works
- 10 The University of Texas MD Anderson Cancer CenterUnited States 9 works
Where is Tumors and Oncological Cases research done?
The largest centres of Tumors and Oncological Cases research in 2022–2025 are New Delhi (India), Beijing (China), Tokyo (Japan) and Chennai (India). Among places with at least 20 works in it, it is an unusually large share of all research in Rabat.
Largest cities, 2022–2025
Where it is the local speciality
- RabatMA · 21.2 works8.9×
Location quotient: how much more of its research is in Tumors and Oncological Cases than the world average.
Where is the best place to study Tumors and Oncological Cases?
Among universities, judged by research, Mohammed V University, Post Graduate Institute of Medical Education and Research and All India Institute of Medical Sciences score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Mohammed V UniversityMorocco | 58.5 | 0.0% | 12.6× | 19 | +182.1% |
| 2 | Post Graduate Institute of Medical Education and ResearchIndia | 54.8 | 5.2% | 11.8× | 14 | +135.3% |
| 3 | All India Institute of Medical SciencesIndia | 53.8 | 1.7% | 10.8× | 25 | +39.7% |
| 4 | Jawaharlal Institute of Post Graduate Medical Education and ResearchIndia | 40.4 | 0.0% | 15.5× | 8 | +225.5% |
| 5 | Institute of Medical SciencesIndia | 39.0 | 0.0% | 10.2× | 12 | +23.1% |
| 6 | All India Institute of Medical Sciences BhubaneswarIndia | 38.5 | 0.8% | 23.3× | 11 | — |
| 7 | Mohamed I UniversityMorocco | 37.8 | 0.0% | 15.0× | 9 | — |
| 8 | Harvard UniversityUnited States | 30.9 | 12.4% | 1.9× | 9 | -24.2% |
| 9 | Datta Meghe Institute of Higher Education and ResearchIndia | 27.7 | 0.0% | 10.2× | 9 | -25.0% |
| 10 | Sichuan UniversityChina | 20.1 | 7.7% | 1.5× | 10 | +9.5% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Tumors and Oncological Cases research growing?
Output in 2018–2022 was 13% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are Tumors and Oncological Cases.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.